Bessemer Group
NVAX icon

Bessemer Group’s Novavax NVAX Stock Holding History

Bessemer Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3K Hold
295
– – ﹤0.01% 2358
2026
Q1 		$2K Sell
295
-28
-9% -$254 ﹤0.01% 2383
2025
Q4 		$2K Buy
323
+295
+1,054% +$2.22K ﹤0.01% 2427
2025
Q3 		$0 Sell
28
-67
-71% -$521 ﹤0.01% 2652
2025
Q2 		$1K Hold
95
– – ﹤0.01% 2324
2025
Q1 		$1K Buy
+95
New +$785 ﹤0.01% 2361
2024
Q4 		– Sell
-70
Closed -$1K – 2621
2024
Q3 		$1K Buy
+70
New +$904 ﹤0.01% 2486

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Bessemer Group's NVAX Position: Q2 2026 in Review

Bessemer Group held its Novavax (NVAX) position steady in Q2 2026 at 295 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #2358.

Bessemer Group first reported a position in NVAX in Q3 2024 and has held it in 7 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Bessemer Group held 295 shares of Novavax worth $3K as of Q2 2026.
  • Bessemer Group left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #2358 holding.
  • Bessemer Group first reported a position in Novavax in Q3 2024 and has held it in 7 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.